BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24190483)

  • 1. In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Int J Oncol; 2014 Jan; 44(1):27-34. PubMed ID: 24190483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
    Roomi MW; Kalinovsky T; Monterrey J; Rath M; Niedzwiecki A
    Int J Oncol; 2013 Dec; 43(6):1787-98. PubMed ID: 24085323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2017 Mar; 37(3):1907-1913. PubMed ID: 28112361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2017 Jun; 37(6):3681-3687. PubMed ID: 28440509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines, inducers and inhibitors modulate MMP-2 and MMP‑9 secretion by human Fanconi anemia immortalized fibroblasts.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2017 Mar; 37(3):1842-1848. PubMed ID: 28098879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
    Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2010 Mar; 23(3):605-14. PubMed ID: 20126997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2013 Oct; 43(4):1027-35. PubMed ID: 23900236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Med Oncol; 2006; 23(2):245-50. PubMed ID: 16720925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2013 Jul; 43(1):39-49. PubMed ID: 23661254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
    Roomi MW; Monterrey JC; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2009 Dec; 22(6):1283-91. PubMed ID: 19885578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Int J Oncol; 2014 Mar; 44(3):986-92. PubMed ID: 24378964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
    Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2010 Sep; 24(3):747-57. PubMed ID: 20664983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts.
    Dickens DS; Cripe TP
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):709-14. PubMed ID: 12972806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of MMP-2 and MMP-9 expression in human cancer cell lines.
    Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2009 May; 21(5):1323-33. PubMed ID: 19360311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2013 Jun; 42(6):1883-9. PubMed ID: 23563849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of matrix metalloproteinase-2 and -9 expression in normal human cell lines.
    Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2009 Mar; 21(3):821-6. PubMed ID: 19212645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.